Karl Broich

President at The Federal Institute for Drugs & Medical Devices

Karl Broich

Karl Broich

President at The Federal Institute for Drugs & Medical Devices

Overview
Career Highlights

The Federal Institute for Drugs & Medical Devices

RelSci Relationships

502

Number of Boards

1

Relationships
RelSci Relationships are individuals Karl Broich likely has professional access to. A relationship does not necessarily indicate a personal connection.

Head of Working Parties Secretariat (Ad Interim) at The European Medicines Agency

Relationship likelihood: Strong

Head, Public Engagement Department at The European Medicines Agency

Relationship likelihood: Strong

Professor of Microbiology at The American University of Rome

Relationship likelihood: Strong

Faculty Member at University of Bonn

Relationship likelihood: Strong

Head of Labelling Review & Standards Office at The European Medicines Agency

Relationship likelihood: Strong

Director, Post-Licensing at Malta Medicines Authority

Relationship likelihood: Strong

Member, Committee for Advanced Therapies at The European Medicines Agency

Relationship likelihood: Strong

General Director at European Brain Research Institute(EBRI)

Relationship likelihood: Strong

Head-Department of Hematology, Oncology, Tumor Immunology & Palliative Care at Helios Klinikum Berlin-Buch

Relationship likelihood: Strong

Former Chief Executive Officer at Medicines & Healthcare Products Regulatory Agency

Relationship likelihood: Strong

Paths to Karl Broich
Potential Connections via
Relationship Science
You
Karl Broich
President at The Federal Institute for Drugs & Medical Devices
Career History
President
2000 - Current

The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is an independent federal higher authority within the portfolio of the Federal Ministry of Health. At the BfArM, roughly 1,000 employees (physicians, pharmacists, chemists, biologists, lawyers, engineers, technical assistants, administrative staff etc.) are involved in the tasks of licensing, improving the safety of medicinal products, detecting and evaluating the risks of medical devices, and monitoring the legal traffic in narcotic drugs and precursors. The most important aim of these activities is to increase the safety of medicinal products and thus that of the patients. Consequently, the BfArM makes a major contribution towards the prevention of risks to public health. The BfArM is located in Bonn. In the course of moving the government's seat from Bonn to Berlin, the Berlin/Bonn Act specified that the authority was to move from Berlin to Bonn as a compensation measure for the Federal City Bonn. Revenue and expenditure of the BfArM are described in Chapter 1510 of the Federal Budget; the sound budgetary management is monitored by the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) and the Federal Audit Office (Bundesrechnungshof). The revenue mainly results from fees charged for official acts. Additional revenues are from mandates assigned by the European Medicines Agency EMA and other healthcare institutions. The BfArM does not engage in any promotion and has no income based on advertising.

Research Associate, Department of Nuclear Medicine
1990 - 1991

The Hospital of the University of Pennsylvania (HUP) is world-renowned for its clinical and research excellence, forging the way for newer and better ways to diagnose and treat illnesses and disorders. Its long and rich history of top-notch patient care began more than two centuries ago with the founding of the nation's first medical school, the University of Pennsylvania. Since 1765 when it first opened its doors, Penn has been dedicated to the training of physicians and the discovery and implementation of new medical knowledge.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Karl Broich. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Karl Broich's profile does not indicate a business or promotional relationship of any kind between RelSci and Karl Broich.